Multimodality treatment in recurrent/metastatic squamous cell carcinoma of head and neck: current therapy, challenges, and future perspectives

被引：5
|
作者：
Pannunzio, Sergio [1 ]
Di Bello, Armando [1 ]
Occhipinti, Denis [1 ]
Scala, Alessandro [1 ]
Messina, Gloria [1 ]
Valente, Giustina [1 ]
Quirino, Michela [1 ]
Di Salvatore, Mariantonietta [1 ]
Tortora, Giampaolo [1 ,2 ]
Cassano, Alessandra [1 ,2 ]
机构：
[1] Ist Ricovero & Cura Carattere Sci IRCCS, Fdn Policlin Univ Agostino Gemelli, Oncol Med, Rome, Italy
[2] IRCCS, Fdn Policlin Univ Agostino Gemelli, Comprehens Canc Ctr, Rome, Italy
来源：
FRONTIERS IN ONCOLOGY | 2024年 / 13卷
关键词：
head and neck; squamous cell carcinoma; recurrent; metastatic; multimodality treatment; surgery; radiation therapy; chemotherapy; QUALITY-OF-LIFE; AND/OR METASTATIC HEAD; PHASE-II TRIAL; SALVAGE SURGERY; OPEN-LABEL; 1ST-LINE TREATMENT; PALLIATIVE RADIOTHERAPY; INVESTIGATORS CHOICE; WEEKLY PACLITAXEL; CANCER PATIENTS;
D O I：
10.3389/fonc.2023.1288695
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Squamous cell carcinoma of the head and neck is a complex group of diseases that presents a challenge to the clinician. The prognosis in the recurrent/metastatic disease is particularly dismal, with a median survival of approximately 12 months. Recently, the personalized and multimodal approach has increased prognosis by integrating locoregional strategies (salvage surgery and stereotactic radiotherapy) and systemic treatments (chemotherapy, immunotherapy, and target therapy). Malnutrition is a significant clinical problem that interferes with dose intensity, and thus, feeding supplementation is critical not only to increase the quality of life but also to improve overall survival. With this review, we want to emphasize the importance of the multidisciplinary approach, quality of life, and nutritional supportive care and to integrate the latest updates of predictive biomarkers for immunotherapy and future therapeutic strategies.
引用
收藏
页数：17
相关论文
共 50 条
  • [21] Efficacy of Multimodality Approach in Patients With Recurrent Head and Neck Squamous Cell Carcinoma
    Hoell, Pascale Alicia
    Elsayad, Khaled
    Berssenbruegge, Hendrik
    Hering, Dominik
    Kittel, Christopher
    Kleinheinz, Johannes
    Bleckmann, Annalen
    Evers, Georg
    Wardelmann, Eva
    Rudack, Claudia
    Eich, Hans Theodor
    ANTICANCER RESEARCH, 2023, 43 (03) : 1255 - 1263
  • [22] Drug Insight: cetuximab in the treatment of recurrent and metastatic squamous cell carcinoma of the head and neck
    Bernier, Jacques
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (12): : 705 - 713
  • [23] Drug Insight: cetuximab in the treatment of recurrent and metastatic squamous cell carcinoma of the head and neck
    Jacques Bernier
    Nature Clinical Practice Oncology, 2008, 5 : 705 - 713
  • [24] Treatment patterns in recurrent/metastatic head and neck squamous cell carcinoma in the US.
    Nadler, Eric S.
    Joo, Seongjung
    Black-Shinn, Jenny
    Boyd, Marley
    Zhuo, Joseph
    Chirovsky, Diana Romana
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [25] Current Aspects and Future Considerations of EGFR Inhibition in Locally Advanced and Recurrent Metastatic Squamous Cell Carcinoma of the Head and Neck
    Patel, Bhamini
    Saba, Nabil F.
    CANCERS, 2021, 13 (14)
  • [26] Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck
    Shin, Dong M.
    Khuri, Fadlo R.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (03): : 443 - 453
  • [27] Immunotherapy in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
    Lasniska, Izabela
    Kolenda, Tomasz
    Teresiak, Anna
    Lamperska, Katarzyna M.
    Galus, Lukasz
    Mackiewicz, Jacek
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (03) : 290 - 303
  • [28] Pembrolizumab and afatinib for recurrent or metastatic head and neck squamous cell carcinoma
    Kao, Hsiang-Fong
    Huang, Huai-Cheng
    Liao, Bin-Chi
    Hong, Ruey-Long
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [29] Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck
    Mirabile, Aurora
    Miceli, Rosalba
    Calderone, Rosa Gioia
    Locati, Laura
    Bossi, Paolo
    Bergamini, Cristiana
    Granata, Roberta
    Perrone, Federica
    Mariani, Luigi
    Licitra, Lisa
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (06): : 1895 - 1902
  • [30] Prognostic Factors in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
    Haring, C. T.
    Rosko, A.
    Heft-Neal, M. E.
    Shuman, A.
    Brenner, J. C.
    Worden, F.
    Spector, M. E.
    Swiecicki, P. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1177 - 1177
12345